Clin2
NCT07621341Likely a fitNot yet recruiting

Maternal Tetanus, Diphtheria, Pertussis Vaccine Study in Thai Pregnancies

PertussisDiphtheriaTetanusVaccine-Preventable Diseases

Part of Infections, Lungs & breathing clinical trials.

This study tests whether giving pregnant women a special tetanus, diphtheria, and pertussis vaccine (TdaP2gen) helps protect their babies from these diseases. Researchers will follow mothers and infants for up to 18 months to measure how well the vaccine works.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
320 people
Ages
birth to 45 years
Study type
Interventional

Who can take part

  • You are a pregnant woman aged 20–45 years in good health
  • You are between 20 and 32 weeks pregnant with a single baby (not multiples)
  • Your pregnancy is low-risk with no known birth defects on ultrasound
  • You have not received certain tetanus/diphtheria/pertussis vaccines in the past 1–2 years
  • You do not have serious medical conditions like diabetes, high blood pressure, kidney disease, or immune disorders
  • You are willing to receive the vaccine and allow your baby to receive infant vaccines plus provide blood samples for testing

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06184542Recruiting· Phase 1
New DTaP vaccine safety trial for children

This trial tests a new combined vaccine for diphtheria, tetanus, and whooping cough (pertussis) in children of different ages. It aims to see if the vaccine is safe and how well it works, helping to protect against these serious diseases.

Dazhou, Sichuan
NCT07418372Not yet recruiting· Phase 1/Phase 2
Testing a reduced-dose diphtheria-tetanus-pertussis vaccine

This trial tests a reduced-dose vaccine that protects against diphtheria, tetanus, and whooping cough (pertussis). It is designed for people 6 years and older who have not recently received other vaccines and are generally healthy.

Chongqing, Chongqing Municipality
NCT07492303Not yet recruiting· Phase 1
Vaccine for adolescents and adults against whooping cough, diphtheria, tetanus

This trial tests a new combination vaccine that protects against whooping cough, diphtheria, and tetanus for people aged 10 and older. It aims to see if the vaccine is safe and helps the body build immunity.

NCT06803524Recruiting· Phase 4
10-year follow-up after a single pertussis shot

This study checks on people who got a single dose of a whooping cough vaccine about 10 years ago in a previous study. Researchers want to see how well the vaccine is still working and if it is still safe.

Bangkok Noi, Bangkok Metropolis
NCT06605755Recruiting
Testing a pentavalent vaccine in 2-month-old babies

This trial tests a combined vaccine that protects against five diseases (diphtheria, tetanus, whooping cough, polio, and Hib) in 2-month-old babies who have already received 4 doses. It aims to check the vaccine's safety and how well it builds immunity.

Nanjing, Jiangsu
NCT07744347Not yet recruiting
Follow-up study on lasting protection from a combined vaccine

This study is checking how long the protection from an earlier vaccine (which combined protection against whooping cough, diphtheria, and tetanus) lasts. If you took part in that earlier trial, this follow-up will help see if you still have protection.

Hear when a new Pertussis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.